FIGURE

Figure 1.

ID
ZDB-FIG-231019-8
Publication
Torraca et al., 2023 - Shigella serotypes associated with carriage in humans establish persistent infection in zebrafish
Other Figures
All Figure Page
Back to All Figure Page
Figure 1.

Shigella establishes persistent infection in zebrafish. A, Experimental diagram of S. sonnei–zebrafish infection. S. sonnei infection undergoes 3 phases: an acute phase (ie, increasing bacterial load), a clearing phase (ie, a steady decrease of bacterial load), and a persistent phase (ie, bacterial load does not further decrease). Diagram created with BioRender.com. B and C, CFU count and survival analysis from zebrafish larvae infected with S. sonnei 53G. Larvae were treated with the antibiotic Nal or left untreated. S. sonnei establishes a persistent infection in zebrafish, even during treatment with a therapeutic antibiotic dose. From 96 hpi, the bacterial load in larvae remains constant over consecutive days. D, CFU count from zebrafish larvae treated with Nal or left untreated during the acute and persistent infection stages. During the acute infection stage (0–24 hpi), S. sonnei is sensitive to antibiotic treatment, while during the persistent infection stage (120–144 hpi), S. sonnei becomes insensitive to antibiotic treatment. Data were analyzed at 24 hours posttreatment. Data: mean ± SEM. Statistics: B, unpaired t test on log10-transformed data against the previous time point; C, log-rank Mantel-Cox test; D, 1-way analysis of variance with Sidak correction. ns, P ≥ .05. *P < .05. ***P < .001. CFU, colony-forming unit; hpi, hours postinfection; hpt, hours posttreatment; Nal, nalidixic acid; ns, nonsignificant.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J. Infect. Dis.